PXAI Audio Feed
10/04 14:03 investing.com

Tempus AI stock rises on Gilead collaboration deal

Tempus AIGilead SciencesAI oncologybiotech collaborationstock riseinvestor confidence
08/04 09:26 defenseworld.net

Gilead Sciences (NASDAQ:GILD) Given New $123.00 Price Target at Royal Bank Of Canada

Gilead Sciencesprice targetanalyst upgradebiopharmaceuticalstock ratingRoyal Bank of Canada
04/04 11:25 defenseworld.net

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of “Moderate Buy” by Analysts

Gilead SciencesGILDModerate BuyAnalyst ConsensusPrice TargetCitigroup
03/04 10:05 defenseworld.net

Gilead Sciences, Inc. $GILD Position Reduced by Aberdeen Group plc

Gilead SciencesAberdeen Groupinstitutional investors13F filingshare saleTrivium Point Advisory
02/04 11:06 defenseworld.net

Bank Pictet & Cie Europe AG Purchases 136,605 Shares of Gilead Sciences, Inc. $GILD

Bank PictetGilead Sciencesinstitutional investorshare purchase13F filingBrighton Jones
30/03 22:53 statnews.com

STAT+: Doctors Without Borders calls Gilead ‘unconsionable’ for refusing to sell HIV prevention drug to organization

Doctors Without BordersGilead ScienceslenacapavirHIV preventionPrEPGlobal Fund
24/03 20:46 defenseworld.net

E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD

E. Ohman JAsset Management ABGilead Sciencesstock holdingsbiopharmaceutical
24/03 00:37 investing.com

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Gilead SciencesOuro Medicinesacquisitionbiotech$2Boncology
23/03 18:42 investing.com

Gilead Sciences nears $2 billion Ouro Medicines acquisition - FT

Gilead SciencesOuro Medicinesacquisitiononcologyantibody‑drug conjugatesprecision medicine
23/03 18:42 investing.com

Gilead Sciences nears $2 billion Ouro Medicines acquisition - FT

Gilead SciencesOuro Medicinesacquisitiononcologyantibody‑drug conjugatesprecision medicine
Comments
Loading...
0